Back to results
CompletedPhase 2

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

NCT01354691

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Medizinische Univeritat Graz, Universitatsklinik fur Neurologie, Auenbruggerplatz 22

Graz, Austria

+18 additional locations

View on ClinicalTrials.gov
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease — TrialFind